Novavax
NVAX
155 hedge funds and large institutions have $218M invested in Novavax in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 31 reducing their positions, and 17 closing their positions.
113% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 31
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
3% more funds holding
Funds holding: 151 → 155 (+4)
0.13% less ownership
Funds ownership: 2.26% → 2.13% (-0.13%)
8% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $2.27M
33% less capital invested
Capital invested by funds: $327M → $218M (-$109M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$9.66M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.4M |
| 3 |
Morgan Stanley
New York
|
+$6.08M |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$5.6M |
| 5 |
Two Sigma Investments
New York
|
+$2.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$12.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.58M |
| 3 |
Millennium Management
New York
|
-$6.13M |
| 4 |
JP Morgan Chase
New York
|
-$4.26M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$4.2M |
NVAX Hedge Fund Activity: Q2 2018 in Review
155 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2018, worth a combined $218M — down 33% from $327M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new NVAX positions and 17 closed out — a net gain of 5 holders — while 66 added to existing stakes and 31 trimmed.
The largest buyer was BlackRock, adding an estimated $9.66M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $12.2M sold.
- 155 institutional investors held Novavax (NVAX) as of Q2 2018, up from 151 in Q1 2018.
- Funds reported $218M of Novavax stock for Q2 2018, down 33% quarter-over-quarter.
- 22 funds opened new Novavax positions in Q2 2018 and 17 closed out, a net change of +5 holders.
- The largest Novavax buyer in Q2 2018 was BlackRock, an estimated $9.66M added.
- The largest Novavax seller in Q2 2018 was Renaissance Technologies, an estimated $12.2M sold.
Based on aggregated 13F filings for Q2 2018.